首页> 外文期刊>International archives of allergy and immunology >Docosahexaenoic acid exerts anti-inflammatory action on human eosinophils through peroxisome proliferator-activated receptor-independent mechanisms
【24h】

Docosahexaenoic acid exerts anti-inflammatory action on human eosinophils through peroxisome proliferator-activated receptor-independent mechanisms

机译:二十二碳六烯酸通过过氧化物酶体增殖物激活的受体独立机制对人嗜酸性粒细胞发挥抗炎作用

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Despite the fact that previous studies have indicated the significant roles of polyunsaturated fatty acids (PUFAs) in the immune system through peroxisome proliferator-activated receptor alpha (PPARα) and PPARγ, the biological functions and the mechanisms of action in eosinophils are poorly understood. Methods: We investigated the functional effects of docosahexaenoic acid (DHA, n-3 PUFA) on human peripheral blood eosinophils, using in vitro systems to test the hypothesis that DHA negatively regulates eosinophil mechanisms through PPARα and PPARγ. Results: Eosinophil apoptosis that spontaneously occurs under normal culture conditions was accelerated in the presence of DHA. In addition, eotaxin-directed eosinophil chemotactic responses were inhibited by pretreatment with DHA, disturbing both the velocity and the directionality of the cell movement. Pharmacological manipulations with specific antagonists indicated that the effects of DHA were not mediated through PPARα and PPARγ, despite the presence of these nuclear receptors. DHA also induced Fas receptor expression and caspase-3 activation that appears to be associated with a proapoptotic effect of DHA. Further, DHA rapidly inhibited the expression of eotaxin receptor C-C chemokine receptor 3 and eotaxin-induced calcium influx and phosphorylation of extracellular signal-regulated kinase. Interestingly, these inhibitory effects were not observed with linoleic acid (n-6 PUFA). Conclusions: The data might explain one of the mechanisms found in previous research showing the favorable effects of n-3 PUFA supplementation on allergic diseases, and provide novel therapeutic strategies to treat eosinophilic disorders.
机译:背景:尽管先前的研究表明,多不饱和脂肪酸(PUFA)通过过氧化物酶体增殖物激活的受体α(PPARα)和PPARγ在免疫系统中起着重要作用,但对嗜酸性粒细胞的生物学功能和作用机理了解得很少。 。方法:我们使用体外系统研究了二十二碳六烯酸(DHA,n-3 PUFA)对人外周血嗜酸性粒细胞的功能作用,以检验DHA通过PPARα和PPARγ负调控嗜酸性粒细胞机制的假设。结果:在DHA的存在下,正常培养条件下自然发生的嗜酸性粒细胞凋亡得以加速。此外,DHA预处理可抑制针对嗜酸性粒细胞趋化因子的嗜酸性粒细胞趋化反应,从而干扰细胞运动的速度和方向。使用特定拮抗剂的药理学操作表明,尽管存在这些核受体,但DHA的作用并未通过PPARα和PPARγ介导。 DHA还诱导Fas受体表达和caspase-3活化,这似乎与DHA的促凋亡作用有关。此外,DHA迅速抑制了趋化因子受体C-C趋化因子受体3的表达和趋化因子诱导的钙内流以及细胞外信号调节激酶的磷酸化。有趣的是,亚油酸(n-6 PUFA)未观察到这些抑制作用。结论:数据可能解释了先前研究中发现的机制之一,该机制显示了补充n-3 PUFA对过敏性疾病的有利作用,并提供了治疗嗜酸性粒细胞疾病的新治疗策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号